VBCN - May 2015 Volume 2, No 1

The costs for inpatient care are significantly affected by the age and sex of patients with multiple sclerosis (MS) who experience disease relapse, according to data presented at the 2015 annual meeting of the American Academy of Neurology.
Read More

Patients with treatment-resistant epilepsy may benefit from a treatment regimen that includes cannabidiol (Epidiolex), a compound in medical marijuana that does not contain psychoactive properties.
Read More

The FDA approved a single-capsule, fixed-dose combination therapy of memantine hydrochloride extended-release and donepezil hydrochloride (Namzaric; Adamas Pharmaceuticals and Actavis) for the treatment of moderate to severe dementia of the Alzheimer’s type in patients who have been stabilized with memantine hydrochloride and donepezil hydrochloride.
Read More

The FDA approved diclofenac sodium (Dyloject; Hospira) injection, a proprietary nonsteroidal anti-inflammatory drug (NSAID) analgesic, for the treatment of adult patients with mild to moderate pain, and moderate to severe pain alone or in combination with opioid analgesics.
Read More

In the year following a relapse, patients with multiple sclerosis remained less productive and their health deteriorated further compared with patients with multiple sclerosis whose disease had not relapsed, according to analyses presented at the 2015 annual meeting of the American Academy of Neurology.
Read More

Clinical and in-hospital process variables are associated with hospital length of stay (LOS) in acute ischemic stroke patients, according to data presented at the 2015 annual meeting of the American Academy of Neurology.
Read More

At the 2015 annual meeting of the American Academy of Neurology, experts engaged in a series of debates that touched on current and controversial issues in the field of neuroscience.
Read More

Multiple sclerosis (MS), a chronic, inflammatory disease of the central nervous system, disrupts the communication between the brain, spinal cord, and other areas of the body.
Read More

In a series of debates at the 2015 annual meeting of the American Academy of Neurology, expert physicians addressed current and controversial issues in neuroscience.
Read More

A recent test-run of a mobile stroke unit (MSU) in Houston, TX, has shown preliminary success in the treatment of patients diagnosed with ischemic stroke.
Read More

Page 1 of 3

Subscribe to Value-Based Care in Neurology

Stay up to date with the latest news in neurology by subscribing to receive the free VBCN e‑Newsletter.